Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Justifying high-cost anticoagulant therapy.

Eric Racine1

  • 1Clinical Pharmacy Services, Harper University Hospital, Detroit Medical Center, Wayne State University, 3990 John R, Detroit, MI 48201, USA. eracine@dmc.org

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|October 29, 2002
PubMed
Summary

Pharmacoeconomics helps pharmacists select low-molecular-weight heparins (LMWHs) for improved patient care and cost savings. Utilizing pharmacoeconomic principles demonstrates LMWHs

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Living Ethics Project to Address Inappropriate Levels of Care: Process and Outcomes.

Journal of bioethical inquiry·2026
Same author

Understanding clinical ethics situations: a co-created repertoire of practices.

BMC medical ethics·2026
Same author

A Living Ethics Project to Address Psychological Distress in Chronic Illness: Process and Outcomes.

Health expectations : an international journal of public participation in health care and health policy·2025
Same author

Open-ended eudemonism in healthcare: epistemological and procedural challenges.

Medicine, health care, and philosophy·2025
Same author

It's a Neurodiverse World: Stories from Neurodivergent People.

Narrative inquiry in bioethics·2025
Same author

Envisioning a Living Ethics Approach to the Allocation of Scarce Resources.

The American journal of bioethics : AJOB·2025

Area of Science:

  • Health Economics
  • Pharmacology
  • Clinical Pharmacy

Background:

  • Modern pharmacy practice requires balancing healthcare budgets with optimal patient outcomes.
  • Pharmacoeconomics offers tools to evaluate the financial and clinical impact of medications.

Purpose of the Study:

  • To examine the application of pharmacoeconomics in selecting low-molecular-weight heparins (LMWHs).
  • To assess how pharmacoeconomics can improve clinical and economic outcomes in anticoagulant therapy.

Main Methods:

  • Review of pharmacoeconomic principles, methods, and data relevant to LMWH selection.
  • Analysis of clinical outcomes and cost-of-care advantages of LMWHs versus traditional agents.
  • Evaluation of cost offsets including reduced hospital stay, heparin-induced thrombocytopenia, and laboratory monitoring.

Related Experiment Videos

Main Results:

  • LMWHs demonstrate superior clinical outcomes and overall cost-of-care benefits compared to unfractionated heparins.
  • Cost savings are achieved through reduced hospital length of stay, lower rates of heparin-induced thrombocytopenia, and decreased monitoring needs.
  • LMWHs facilitate cost-effective bridge therapy and support targeted dose-reduction programs.

Conclusions:

  • Applying pharmacoeconomics in LMWH selection aids pharmacy professionals in achieving better clinical and economic results.
  • Pharmacoeconomics provides a framework for documenting cost savings, cost avoidance, and justifying resource allocation.